Okay, let's tackle this question about drugs contraindicated in G6PD deficiency. First, I need to recall what G6PD is. Glucose-6-phosphate dehydrogenase is an enzyme in the pentose phosphate pathway that helps protect red blood cells from oxidative stress. If someone is deficient in this enzyme, their RBCs can't handle oxidative stress well, leading to hemolysis when exposed to certain drugs or foods.

The question is asking which drug is contraindicated in such patients. Common drugs known to cause hemolysis in G6PD deficiency include antimalarials like primaquine, sulfonamides, nitrofurantoin, and certain antibiotics. Let me think of the options that are typically listed. For example, primaquine is a big one. Then there's dapsone, which is used for leprosy. Also, some antifungals like nifuratel might be involved.

Wait, the correct answer here is likely primaquine. Let me confirm. Primaquine is an 8-aminoquinoline antimalarial that causes oxidative stress in RBCs, especially in G6PD-deficient individuals. It leads to hemolysis because the enzyme isn't there to protect the cells. So the mechanism is the generation of reactive oxygen species that the RBCs can't neutralize.

Now, the other options. If one of the options is chloroquine, that's not contraindicated. Chloroquine is a 4-aminoquinoline and doesn't have the same issue. Sulfamethoxazole is a sulfonamide, which can be a problem, but maybe it's not the most classic one. Nitrofurantoin is another one to avoid. Let's say the options include these.

So the correct answer is primaquine. The clinical pearl here is to remember the mnemonic: "I SING OF PRIMAQUINE"—each letter stands for a drug class: Isoniazid, Sulfonamides, Nitrofurantoin, Primaquine, Aspirin, Quinacrine, etc. That helps recall the contraindicated drugs in G6PD deficiency.

I need to structure the explanation with the core concept, why the correct answer is right, why others are wrong, and a clinical pearl. Let me make sure each section is concise and covers the necessary points without being too wordy. Also, check the character count to stay within the limit.

**Core Concept**
G6PD deficiency is an X-linked enzymatic disorder that impairs red blood cell (RBC) protection against oxidative stress. Certain drugs trigger hemolysis in these patients by increasing reactive oxygen species (ROS), overwhelming the RBC's antioxidant capacity. Key culprits include antimalarials, sulfonamides, nitrofurans, and dapsone.

**Why the Correct Answer is Right**
**Primaquine** is a 8-aminoquinoline antimalarial that induces oxidative stress via redox cycling, generating ROS. In G6PD-deficient RBCs, the impaired pentose phosphate pathway cannot replenish NADPH, leading to glutathione deficiency and membrane damage. This causes acute hemolytic anemia, typically within 24–72 hours of administration.

**Why Each Wrong Option is Incorrect**
**Option A

✓ Correct Answer: D. All